• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 - Product Image

Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

  • Published: January 2012
  • Region: Chile
  • 143 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A
  • Gen-Probe Incorporated
  • HORIBA, Ltd.
  • MORE

Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

Summary

”Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Chile In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In Chile
3.1 In Vitro Diagnostics, Chile, Overall Revenue ($m), USD Actual, 2003-2017
3.2 In Vitro Diagnostics, Chile, Company share (2009-2010)
4 Clinical Chemistry In Chile
4.1 Clinical Chemistry Overall Revenue (2003-2017)
4.1.1 Clinical Chemisty Analyzers Revenue (2003-2017)
4.1.2 Urine Analysis Revenue (2003-2017)
4.2 Clinical Chemistry Distribution Share (2009-2010)
4.3 Clinical Chemistry, Chile, Company share (2009-2010)
5 Genetic Testing In Chile
5.1 Genetic Testing Overall Revenue (2003-2017)
5.2 Genetic Testing Distribution Share (2009-2010)
5.3 Genetic Testing, Chile, Company share (2009-2010)
6 Haematology In Chile
6.1 Haematology Overall Revenue (2003-2017)
6.1.1 Haematology Reagents Revenue (2003-2017)
6.1.2 Immunohaematology Revenue (2003-2017)
6.1.3 Haemostasis Revenue (2003-2017)
6.1.4 Haematology Rapid Tests Revenue (2003-2017)
6.1.5 Haematology Cell Counters Revenue (2003-2017)
6.2 Haematology Distribution Share (2009-2010)
6.3 Haematology, Chile, Company share (2009-2010)
7 Histology And Cytology In Chile
7.1 Histology And Cytology Overall Revenue (2003-2017)
7.2 Histology And Cytology Distribution Share (2009-2010)
7.3 Histology And Cytology, Chile, Company share (2009-2010)
8 Immuno Chemistry In Chile
8.1 Immuno Chemistry Overall Revenue (2003-2017)
8.1.1 Disease Specific Immunochemistry Revenue (2003-2017)
8.1.2 Drugs of Abuse / Toxicology Revenue (2003-2017)
8.1.3 Endocrinology Tests Revenue (2003-2017)
8.1.4 Therapeutic Drug Monitoring Revenue (2003-2017)
8.1.5 Immunochemistry Analyzers Revenue (2003-2017)
8.2 Immuno Chemistry Distribution Share (2009-2010)
8.3 Immuno Chemistry, Chile, Company share (2009-2010)
9 Infectious Immunology In Chile
9.1 Infectious Immunology Overall Revenue (2003-2017)
9.2 Infectious Immunology Distribution Share (2009-2010)
9.3 Infectious Immunology, Chile, Company share (2009-2010)
10 Microbiology Culture In Chile
10.1 Microbiology Culture Overall Revenue (2003-2017)
10.1.1 Microbiology Analyzers Revenue (2003-2017)
10.2 Microbiology Culture Distribution Share (2009-2010)
10.3 Microbiology Culture, Chile, Company share (2009-2010)
11 Overview of Key Companies in Chile In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.2 Siemens Healthcare
11.2.1 Company Overview
11.3 Abbott Laboratories
11.3.1 Company Overview
11.4 bioMerieux S.A.
11.4.1 Company Overview
11.5 Ortho-Clinical Diagnostics Inc.
11.5.1 Company Overview
11.6 Beckman Coulter, Inc.
11.6.1 Company Overview
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Company Overview
11.8 Sysmex Corporation
11.8.1 Company Overview
11.9 Becton, Dickinson and Company
11.9.1 Company Overview
11.10 HORIBA, Ltd.
11.10.1 Company Overview
11.11 DiaSorin S.p.A
11.11.1 Company Overview
11.12 Alere Inc.
11.12.1 Company Overview
11.13 Mindray Medical International Limited
11.13.1 Company Overview
11.14 Thermo Fisher Scientific Inc.
11.14.1 Company Overview
11.15 Qiagen N.V.
11.15.1 Company Overview
11.16 Phadia AB
11.16.1 Company Overview
11.17 Grifols, S.A.
11.17.1 Company Overview
11.18 Gen-Probe Incorporated
11.18.1 Company Overview
11.19 PerkinElmer, Inc.
11.19.1 Company Overview
11.20 DIAGNOSTICA STAGO, Inc.
11.20.1 Company Overview
11.21 Life Technologies Corporation
11.21.1 Company Overview
11.22 Danaher Corporation
11.22.1 Company Overview
12 APPENDIX
12.1 Global Markets Direct Research Methodology
12.2 Definitions of Markets Covered in the Report
12.2.1 In Vitro Diagnostics
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panel Validation
12.8 Currency Conversion
12.9 Contact Us
12.10 Disclaimer

1.1 List of Tables
Table 1: In Vitro Diagnostics, Chile, Overall Revenue ($m), USD Actual, 2003-2017
Table 2: In Vitro Diagnostics, Chile, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 3: In Vitro Diagnostics, Chile, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 4: In Vitro Diagnostics, Chile, Company share by Revenue ($m), USD Actual, 2009-2010
Table 5: Clinical Chemistry, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 6: Clinical Chemistry, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 7: Clinical Chemisty Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 8: Clinical Chemisty Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 9: Urine Analysis, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 10: Urine Analysis, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 11: Clinical Chemistry, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 12: Clinical Chemistry, Chile, Company share by Revenue ($m), USD Actual 2009-2010
Table 13: Genetic Testing, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 14: Genetic Testing, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 15: Genetic Testing, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 16: Genetic Testing, Chile, Company share by Revenue ($m), USD Actual 2009-2010
Table 17: Haematology, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 18: Haematology, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 19: Haematology Reagents, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 20: Haematology Reagents, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 21: Immunohaematology, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 22: Immunohaematology, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 23: Haemostasis, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 24: Haemostasis, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 25: Haematology Rapid Tests, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 26: Haematology Rapid Tests, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 27: Haematology Cell Counters, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 28: Haematology Cell Counters, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 29: Haematology, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 30: Haematology, Chile, Company share by Revenue ($m), USD Actual 2009-2010
Table 31: Histology And Cytology, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 32: Histology And Cytology, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 33: Histology And Cytology, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 34: Histology And Cytology, Chile, Company share by Revenue ($m), USD Actual 2009-2010
Table 35: Immuno Chemistry, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 36: Immuno Chemistry, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 37: Disease Specific Immunochemistry, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 38: Disease Specific Immunochemistry, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 39: Drugs of Abuse / Toxicology, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 40: Drugs of Abuse / Toxicology, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 41: Endocrinology Tests, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 42: Endocrinology Tests, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 43: Therapeutic Drug Monitoring, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 44: Therapeutic Drug Monitoring, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 45: Immunochemistry Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 46: Immunochemistry Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 47: Immuno Chemistry, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 48: Immuno Chemistry, Chile, Company share by Revenue ($m), USD Actual 2009-2010
Table 49: Infectious Immunology, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 50: Infectious Immunology, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 51: Infectious Immunology, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 52: Infectious Immunology, Chile, Company share by Revenue ($m), USD Actual 2009-2010
Table 53: Microbiology Culture, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 54: Microbiology Culture, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 55: Microbiology Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 56: Microbiology Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 57: Microbiology Culture, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 58: Microbiology Culture, Chile, Company share by Revenue ($m), USD Actual 2009-2010
Table 59: USD to Local Currency, Chile, Average Actual Rate 2003-2010

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Chile, Overall Revenue ($m), USD Actual, 2003-2017
Figure 2: In Vitro Diagnostics, Chile, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 3: In Vitro Diagnostics, Chile, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 4: In Vitro Diagnostics, Chile, Company share (%), 2010
Figure 5: Clinical Chemistry, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 6: Clinical Chemistry, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 7: Clinical Chemisty Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 8: Clinical Chemisty Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 9: Urine Analysis, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 10: Urine Analysis, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 11: Clinical Chemistry, Chile, Company share (%), 2010
Figure 12: Genetic Testing, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 13: Genetic Testing, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 14: Genetic Testing, Chile, Company share (%), 2010
Figure 15: Haematology, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 16: Haematology, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 17: Haematology Reagents, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 18: Haematology Reagents, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 19: Immunohaematology, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 20: Immunohaematology, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 21: Haemostasis, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 22: Haemostasis, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 23: Haematology Rapid Tests, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 24: Haematology Rapid Tests, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 25: Haematology Cell Counters, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 26: Haematology Cell Counters, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 27: Haematology, Chile, Company share (%), 2010
Figure 28: Histology And Cytology, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 29: Histology And Cytology, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 30: Histology And Cytology, Chile, Company share (%), 2010
Figure 31: Immuno Chemistry, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 32: Immuno Chemistry, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 33: Disease Specific Immunochemistry, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 34: Disease Specific Immunochemistry, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 35: Drugs of Abuse / Toxicology, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 36: Drugs of Abuse / Toxicology, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 37: Endocrinology Tests, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 38: Endocrinology Tests, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 39: Therapeutic Drug Monitoring, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 40: Therapeutic Drug Monitoring, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 41: Immunochemistry Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 42: Immunochemistry Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 43: Immuno Chemistry, Chile, Company share (%), 2010
Figure 44: Infectious Immunology, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 45: Infectious Immunology, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 46: Infectious Immunology, Chile, Company share (%), 2010
Figure 47: Microbiology Culture, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 48: Microbiology Culture, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 49: Microbiology Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 50: Microbiology Analyzers, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 51: Microbiology Culture, Chile, Company share (%), 2010
Figure 52: Global Markets Direct Methodology

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
bioMerieux S.A.
Ortho-Clinical Diagnostics Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Becton, Dickinson and Company
HORIBA, Ltd.
DiaSorin S.p.A
Alere Inc.
Mindray Medical International Limited
Thermo Fisher Scientific Inc.
Qiagen N.V.
Phadia AB
Grifols, S.A.
Gen-Probe Incorporated
PerkinElmer, Inc.
DIAGNOSTICA STAGO, Inc.
Life Technologies Corporation
Danaher Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos